Merck testimony struck in latest courtroom fracas

The judge hearing the second Vioxx case handed Merck another setback on Friday, striking the testimony of a company researcher--and Merck's first defense witness--after saying that a review of his remarks sickened her. Judge Carol Higbee said that Dr. Briggs Morrison was not an expert on the trials he discussed and that Merck had seriously misled her over what he would discuss. Merck's attorney and the judge then engaged in a heated exchange with the judge refusing to declare a mistrial for the sixth time.

- read this AP report for more

Suggested Articles

Tango Therapeutics is ditching its digs in Kendall Square to move into a new building in Boston’s Fenway neighborhood. Third Rock is coming, too.

The Japanese drugmaker pulled the trigger on the deal after getting a look at phase 1 data on the glutenase TAK-062.

Vanda Pharmaceuticals is hoping to try again with an amended trial after its experimental skin drug tradipitant failed a phase 3 test.